The cost of Myrbetriq can vary significantly depending on factors such as insurance coverage, pharmacy, and whether generic alternatives are available. Without specific insurance details or location, providing an exact figure is difficult.
How much does Myrbetriq typically cost without insurance?
For individuals paying out-of-pocket, the average retail price for a 30-day supply of Myrbetriq (mirabegron) 25 mg or 50 mg extended-release tablets can range from approximately $400 to over $500 [1]. This price can fluctuate based on the pharmacy and any available discounts.
Are there any patient assistance programs for Myrbetriq?
Yes, Astellas Pharma, the manufacturer of Myrbetriq, offers a savings program for eligible commercially insured patients. The Myrbetriq Savings Card may help reduce out-of-pocket costs for those with commercial insurance [2]. Information on eligibility and how to apply for these programs is available through the manufacturer's website or patient assistance portals.
When does Myrbetriq's patent expire?
The patent landscape for Myrbetriq is complex and involves multiple patents. U.S. Patent Nos. 7,932,257 and 8,557,800, among others, cover Myrbetriq. DrugPatentWatch.com indicates that the earliest expiration date for some of these patents is around October 2028, though other related patents may extend beyond that [3]. The exact date for market exclusivity can be influenced by various patent challenges and extensions.
Can generic versions of Myrbetriq be produced?
The potential for generic versions of Myrbetriq depends on the expiry of its patents and any potential exclusivities. Once patents expire and regulatory hurdles are cleared, generic manufacturers can seek approval to market their versions of mirabegron. The availability of generics typically leads to a significant reduction in drug costs.
How does the cost of Myrbetriq compare to other overactive bladder medications?
Myrbetriq is often prescribed when other treatments for overactive bladder (OOB) have not been effective or tolerated. Compared to older, anticholinergic medications for OOB, Myrbetriq generally has a higher price point. However, its mechanism of action, targeting the beta-3 adrenergic receptor, offers a different therapeutic approach that may be beneficial for some patients who experience side effects with other drug classes.
Sources:
1. GoodRx. (n.d.). Myrbetriq Prices, Coupons & Savings Tips. Retrieved from https://www.goodrx.com/myrbetriq
2. Myrbetriq. (n.d.). Savings & Support. Retrieved from https://www.myrbetriq.com/savings-support
3. DrugPatentWatch. (n.d.). Mirabegron Drug Patent Information. Retrieved from https://drugpatentwatch.com/drugs/mirabegron